Lopez BGC, Kohale IN, Du Z, Korsunsky I, Abdelmoula WM, Dai Y, Stopka SA, Gaglia G, Randall EC, Regan MS et al..  2022.  Multimodal platform for assessing drug distribution and response in clinical trials.. Neuro Oncol. 24(1):64-77.

Stopfer LE, D'Souza AD, White FM.  2021.  1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs.. Immunooncol Technol. 11:100042.

Stopfer LE, Gajadhar AS, Patel B, Gallien S, Frederick DT, Boland GM, Sullivan RJ, White FM.  2021.  Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants.. Proc Natl Acad Sci U S A. 118(37)

Basu SS, Agar NYR.  2021.  Bringing Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging to the Clinics.. Clin Lab Med. 41(2):309-324.

Marin B-M, Porath KA, Jain S, Kim M, Conage-Pough JE, Oh J-H, Miller CL, Talele S, Kitange GJ, Tian S et al..  2021.  Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma.. Neuro Oncol. 23(12):2042-2053.

Stopfer LE, Flower CT, Gajadhar AS, Patel B, Gallien S, Lopez-Ferrer D, White FM.  2021.  High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human Tumors.. Cancer Res. 81(9):2495-2509.

Leddy OK, White FM, Bryson BD.  2021.  Leveraging Immunopeptidomics To Study and Combat Infectious Disease.. mSystems. 6(4):e0031021.

Abdelmoula WM, Lopez BGimenez-Ca, Randall EC, Kapur T, Sarkaria JN, White FM, Agar JN, Wells WM, Agar NYR.  2021.  Peak learning of mass spectrometry imaging data using artificial neural networks.. Nat Commun. 12(1):5544.

Gerritsen JS, White FM.  2021.  Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells.. Expert Rev Proteomics. 18(8):661-674.

Kohale IN, Burgenske DM, Mladek AC, Bakken KK, Kuang J, Boughey JC, Wang L, Carter JM, Haura EB, Goetz MP et al..  2021.  Quantitative analysis of tyrosine phosphorylation from FFPE tissues reveals patient-specific signaling networks.. Cancer Res.

Stopfer LE, Conage-Pough JE, White FM.  2021.  Quantitative consequences of protein carriers in immunopeptidomics and tyrosine phosphorylation MS analyses.. Mol Cell Proteomics. :100104.

Shaaya M, Fauser J, Zhurikhina A, Conage-Pough JE, Huyot V, Brennan M, Flower CT, Matsche J, Khan S, Natarajan V et al..  2020.  Light-regulated allosteric switch enables temporal and subcellular control of enzyme activity.. Elife. 9

Randall EC, Lopez BGC, Peng S, Regan MS, Abdelmoula WM, Basu SS, Santagata S, Yoon H, Haigis MC, Agar JN et al..  2020.  Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma.. Cancer Res. 80(6):1258-1267.

Morshed N, Ralvenius WT, Nott A, L Watson A, Rodriguez FH, Akay LA, Joughin BA, Pao P-C, Penney J, LaRocque L et al..  2020.  Phosphoproteomics identifies microglial Siglec-F inflammatory response during neurodegeneration.. Mol Syst Biol. 16(12):e9819.

Freedman RA, Gelman RS, Agar NYR, Santagata S, Randall EC, Lopez BGimenez-Ca, Connolly RM, Dunn IF, Van Poznak CH, Anders CK et al..  2020.  Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.. Clin Breast Cancer. 20(2):145-151.e2.

Gerosa L, Chidley C, Fröhlich F, Sanchez G, Lim SKyun, Muhlich J, Chen J-Y, Vallabhaneni S, Baker GJ, Schapiro D et al..  2020.  Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells.. Cell Syst. 11(5):478-494.e9.

Rockne RC, Hawkins-Daarud A, Swanson KR, Sluka JP, Glazier JA, Macklin P, Hormuth DA, Jarrett AM, Lima EABF, J Oden T et al..  2019.  The 2019 mathematical oncology roadmap.. Phys Biol. 16(4):041005.

Abdelmoula WM, Regan MS, Lopez BGC, Randall EC, Lawler S, Mladek AC, Nowicki MO, Marin BM, Agar JN, Swanson KR et al..  2019.  Automatic 3D Nonlinear Registration of Mass Spectrometry Imaging and Magnetic Resonance Imaging Data.. Anal Chem. 91(9):6206-6216.

Gampa G, Kim M, Mohammad AS, Parrish KE, Mladek AC, Sarkaria JN, Elmquist WF.  2019.  Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases.. J Pharmacol Exp Ther. 368(3):446-461.

Kim M, Laramy JK, Mohammad AS, Talele S, Fisher J, Sarkaria JN, Elmquist WF.  2019.  Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and -Deficient Mice.. Drug Metab Dispos. 47(4):393-404.

Massey SC, Hawkins-Daarud A, Gallaher J, Anderson ARA, Canoll P, Swanson KR.  2019.  Lesion Dynamics Under Varying Paracrine PDGF Signaling in Brain Tissue.. Bull Math Biol.

Basu SS, McMinn MH, Lopez BGimenez-Ca, Regan MS, Randall EC, Clark AR, Cox CR, Agar NYR.  2019.  Metal Oxide Laser Ionization Mass Spectrometry Imaging (MOLI MSI) Using Cerium(IV) Oxide.. Anal Chem. 91(10):6800-6807.

Koohi-Moghadam M, Borad M, Tran N, Swanson K, Boardman L, Sun H, Wang J.  2019.  MetaMarker: a de novo pipeline for discovering novel metagenomic biomarkers.. Bioinformatics.

White FM, Gatenby RA, Fischbach C.  2019.  The Physics of Cancer.. Cancer Res. 79(9):2107-2110.

Hawkins-Daarud A, Johnston SK, Swanson KR.  2019.  Quantifying Uncertainty and Robustness in a Biomathematical Model-Based Patient-Specific Response Metric for Glioblastoma.. JCO Clin Cancer Inform. 3:1-8.